Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Design and structural analysis of aromatic inhibitors of type II dehydroquinase from Mycobacterium tuberculosis.

Howard NI, Dias MV, Peyrot F, Chen L, Schmidt MF, Blundell TL, Abell C.

ChemMedChem. 2015 Jan;10(1):116-33. doi: 10.1002/cmdc.201402298. Epub 2014 Sep 18.

PMID:
25234229
2.

Discovery of Schaeffer's acid analogues as lead structures of mycobacterium tuberculosis type II dehydroquinase using a rational drug design approach.

Schmidt MF, Korb O, Howard NI, Dias MV, Blundell TL, Abell C.

ChemMedChem. 2013 Jan;8(1):54-8. doi: 10.1002/cmdc.201200508. Epub 2012 Nov 21.

PMID:
23169689
3.

Hierarchical virtual screening for the discovery of new molecular scaffolds in antibacterial hit identification.

Ballester PJ, Mangold M, Howard NI, Robinson RL, Abell C, Blumberger J, Mitchell JB.

J R Soc Interface. 2012 Dec 7;9(77):3196-207. doi: 10.1098/rsif.2012.0569. Epub 2012 Aug 29.

4.

Structural investigation of inhibitor designs targeting 3-dehydroquinate dehydratase from the shikimate pathway of Mycobacterium tuberculosis.

Dias MV, Snee WC, Bromfield KM, Payne RJ, Palaninathan SK, Ciulli A, Howard NI, Abell C, Sacchettini JC, Blundell TL.

Biochem J. 2011 Jun 15;436(3):729-39. doi: 10.1042/BJ20110002.

PMID:
21410435
6.

Neurobehavioral symptoms and family functioning in traumatically brain-injured adults.

Groom KN, Shaw TG, O'Connor ME, Howard NI, Pickens A.

Arch Clin Neuropsychol. 1998 Nov;13(8):695-711.

PMID:
14590629

Supplemental Content

Loading ...
Support Center